Aspira engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
$7.01 +0.30 (4.39%)
As of 03/08/2021 11:45:24 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.